Life Sciences Switzerland (LS2)

Life Sciences Switzerland (LS2) is a non-profit organization dedicated to advancing biological sciences within the Swiss Academic Community, and to addressing the social, ethical, and economic issues raised by the rapid progress of the biomedical and life sciences.

Originally founded around Prof. Eward Weibel as USGEB (Union of Swiss Societies for Experimental Biology) in 1969, the society has a history of nearly 50 years in federating researchers from various Life Sciences disciplines and in promoting their interests towards the public. In 2012, USGEB changed its name to LS2 (Life Sciences Switzerland) and in 2016, three of the founding societies (Swiss Society for Molecular and Cellular Biosciences, Swiss Proteomics Society, and Swiss Physiological Society) merged, making LS2 the largest Life Sciences Society in Switzerland.

Our actions

LS2 is the society that integrates all facets of the life sciences, from Biochemistry to Physiology. We are actively reaching out to partner societies, organise workshops, satellite, and section meetings, our big annual meeting, and provide travel grants for young researchers to kick-start their academic career. If you are interested in joining LS2, please visit our main website.

LS2 is member of the Platform Biology of the Swiss Academy of Sciences (SCNAT). SCNAT provides substantial funding to LS2 that make our actions and events possible.



  • Events

2019
Sep 13
Flyerfoto_SGV_LS2_2019.jpeg
  • Swiss Laboratory Animal Science Association
  • LS2 Life Sciences Switzerland
  • Symposium
  • Zürich

Joint Symposium LS2/SGV 2019 “Tierversuche im Dialog”

Die Life Sciences Gesellschaft (LS2) und die Schweizerische Gesellschaft für Versuchstierkunde (SGV) möchten Sie hiermit zu unserem gemeinsames Symposium «Tierversuche im Dialog» einladen.
In der Schweiz gibt es im Moment verschiedene Initiativen, welche entweder das totale Verbot von Tier- und Humanversuchen oder aber die Abschaffung der höchsten Belastung für die Tiere fordern. Die Annahme dieser Initiativen hätte weitreichende Konsequenzen für die Schweiz, unter anderem für die biomedizinische Forschung und die Versorgung der Patientinnen und Patienten mit neuen Medikamenten.

Contact

LS2 Life Sciences Switzerland
University of Zurich Institute of Molecular Life Sciences
Winterthurerstrasse 190
8057 Zürich
Switzerland


E-mail